Fig. 4
From: Nanoparticles for the treatment of glaucoma-associated neuroinflammation
(Adapted from “Anatomy of the Human Eye”, “Structure of the Retina” and “Tear Film Structure”, by BioRender.com (2022). Retrieved and edited from https://app.biorender.com/biorender-templates)
Overview of nanoparticle-mediated ocular drug delivery through the corneal barrier (a) and blood-retinal barrier (b). The potential advantages of the use of nanoparticles as an approach for improving current glaucoma medication (c)